Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vesico-Ureteral Reflux | 12 | 2021 | 433 | 2.570 |
Why?
|
Urinary Tract Infections | 8 | 2021 | 804 | 2.010 |
Why?
|
Hydronephrosis | 5 | 2023 | 274 | 1.940 |
Why?
|
Ureteral Obstruction | 8 | 2022 | 293 | 1.920 |
Why?
|
Glycomics | 3 | 2021 | 118 | 1.710 |
Why?
|
Tandem Mass Spectrometry | 8 | 2021 | 1197 | 1.310 |
Why?
|
Urine | 5 | 2020 | 362 | 1.190 |
Why?
|
Polysaccharides | 7 | 2021 | 1020 | 1.100 |
Why?
|
Nephrectomy | 5 | 2018 | 928 | 1.050 |
Why?
|
Urinary Tract | 7 | 2019 | 305 | 1.030 |
Why?
|
Urologic Diseases | 5 | 2019 | 246 | 1.020 |
Why?
|
Proteomics | 10 | 2021 | 3913 | 1.010 |
Why?
|
Robotics | 7 | 2010 | 807 | 1.000 |
Why?
|
Kidney | 13 | 2023 | 7063 | 0.990 |
Why?
|
Glycoproteins | 5 | 2016 | 2200 | 0.910 |
Why?
|
Glycosylation | 6 | 2021 | 1099 | 0.830 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2022 | 71 | 0.800 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2022 | 60 | 0.800 |
Why?
|
Proteome | 3 | 2020 | 1890 | 0.790 |
Why?
|
Pelvic Neoplasms | 1 | 2023 | 249 | 0.730 |
Why?
|
Laparoscopy | 10 | 2018 | 2037 | 0.710 |
Why?
|
Rhabdomyosarcoma | 1 | 2023 | 358 | 0.680 |
Why?
|
Kidney Pelvis | 4 | 2022 | 191 | 0.620 |
Why?
|
Radionuclide Imaging | 3 | 2020 | 1987 | 0.600 |
Why?
|
Cryptorchidism | 2 | 2021 | 153 | 0.600 |
Why?
|
Urologic Surgical Procedures | 5 | 2018 | 281 | 0.590 |
Why?
|
Chromatography, Liquid | 6 | 2020 | 996 | 0.530 |
Why?
|
Adrenalectomy | 1 | 2018 | 347 | 0.510 |
Why?
|
Urography | 4 | 2019 | 316 | 0.490 |
Why?
|
Proteins | 4 | 2013 | 6001 | 0.490 |
Why?
|
Urothelium | 1 | 2017 | 275 | 0.480 |
Why?
|
Urinary Bladder | 2 | 2023 | 1155 | 0.470 |
Why?
|
Cicatrix | 2 | 2020 | 798 | 0.460 |
Why?
|
Ureter | 4 | 2015 | 364 | 0.450 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2014 | 174 | 0.440 |
Why?
|
Bladder Exstrophy | 2 | 2022 | 107 | 0.440 |
Why?
|
Wilms Tumor | 1 | 2016 | 378 | 0.430 |
Why?
|
Lymph Node Excision | 2 | 2018 | 1267 | 0.400 |
Why?
|
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2012 | 26 | 0.400 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 505 | 0.400 |
Why?
|
Urogenital Abnormalities | 3 | 2019 | 255 | 0.360 |
Why?
|
Microwaves | 1 | 2012 | 184 | 0.360 |
Why?
|
Infant | 23 | 2021 | 36485 | 0.350 |
Why?
|
Urethral Stricture | 1 | 2010 | 50 | 0.350 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2023 | 2186 | 0.350 |
Why?
|
Cystostomy | 2 | 2007 | 25 | 0.340 |
Why?
|
Child | 26 | 2023 | 80771 | 0.320 |
Why?
|
Child, Preschool | 22 | 2022 | 42606 | 0.320 |
Why?
|
Replantation | 1 | 2010 | 145 | 0.310 |
Why?
|
Ultrasonography | 7 | 2020 | 6000 | 0.300 |
Why?
|
Immunoglobulin G | 3 | 2014 | 4560 | 0.290 |
Why?
|
Technetium Tc 99m Dimercaptosuccinic Acid | 3 | 2020 | 81 | 0.290 |
Why?
|
Ureteral Diseases | 1 | 2007 | 63 | 0.280 |
Why?
|
Nephrostomy, Percutaneous | 1 | 2007 | 76 | 0.270 |
Why?
|
Cloaca | 1 | 2006 | 52 | 0.270 |
Why?
|
Kidney Transplantation | 4 | 2007 | 4268 | 0.260 |
Why?
|
Body Burden | 1 | 2006 | 158 | 0.260 |
Why?
|
Protein Processing, Post-Translational | 2 | 2013 | 1965 | 0.250 |
Why?
|
Proteinuria | 1 | 2008 | 613 | 0.240 |
Why?
|
Male | 44 | 2023 | 364203 | 0.240 |
Why?
|
Humans | 70 | 2023 | 767040 | 0.230 |
Why?
|
Urethral Obstruction | 2 | 2019 | 56 | 0.230 |
Why?
|
Kidney Neoplasms | 2 | 2018 | 4282 | 0.220 |
Why?
|
Propylene Glycols | 1 | 2003 | 91 | 0.220 |
Why?
|
Cattle | 3 | 2014 | 3813 | 0.210 |
Why?
|
Carbohydrate Sequence | 2 | 2014 | 411 | 0.210 |
Why?
|
Safety Management | 1 | 2008 | 765 | 0.210 |
Why?
|
Kidney Calculi | 1 | 2007 | 458 | 0.210 |
Why?
|
Radiation Protection | 1 | 2006 | 428 | 0.200 |
Why?
|
Testicular Neoplasms | 2 | 2021 | 806 | 0.200 |
Why?
|
Histocompatibility | 1 | 2003 | 322 | 0.200 |
Why?
|
Retroperitoneal Space | 2 | 2018 | 175 | 0.200 |
Why?
|
Urethra | 2 | 2019 | 406 | 0.200 |
Why?
|
Female | 37 | 2023 | 396660 | 0.200 |
Why?
|
Renal Artery | 1 | 2003 | 355 | 0.190 |
Why?
|
Blood Component Removal | 1 | 2002 | 124 | 0.190 |
Why?
|
Hernia, Umbilical | 1 | 2022 | 102 | 0.190 |
Why?
|
Uromodulin | 1 | 2021 | 48 | 0.180 |
Why?
|
Aneurysm, False | 1 | 2003 | 263 | 0.180 |
Why?
|
Fetal Diseases | 1 | 2006 | 915 | 0.180 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2227 | 0.180 |
Why?
|
Molecular Sequence Annotation | 2 | 2013 | 526 | 0.180 |
Why?
|
Creatinine | 3 | 2020 | 1916 | 0.180 |
Why?
|
Adolescent | 18 | 2022 | 89046 | 0.170 |
Why?
|
Mannose | 1 | 2020 | 121 | 0.170 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2022 | 461 | 0.170 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2020 | 67 | 0.170 |
Why?
|
Fucose | 1 | 2020 | 115 | 0.170 |
Why?
|
Feasibility Studies | 5 | 2020 | 5311 | 0.170 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2022 | 156 | 0.170 |
Why?
|
Fever | 2 | 2021 | 1605 | 0.170 |
Why?
|
Abnormalities, Multiple | 2 | 2022 | 1424 | 0.160 |
Why?
|
Radiation Injuries | 1 | 2006 | 1196 | 0.160 |
Why?
|
Pelvic Pain | 2 | 2021 | 300 | 0.160 |
Why?
|
Cystectomy | 1 | 2023 | 603 | 0.150 |
Why?
|
Radiopharmaceuticals | 3 | 2020 | 2702 | 0.150 |
Why?
|
Recurrence | 3 | 2020 | 8504 | 0.150 |
Why?
|
Contrast Media | 3 | 2020 | 5329 | 0.150 |
Why?
|
Retrospective Studies | 17 | 2022 | 81659 | 0.150 |
Why?
|
Catheterization, Central Venous | 1 | 2002 | 537 | 0.140 |
Why?
|
Wounds, Nonpenetrating | 1 | 2003 | 807 | 0.140 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2019 | 270 | 0.140 |
Why?
|
Image Enhancement | 2 | 2020 | 2867 | 0.130 |
Why?
|
Receptors, Nicotinic | 1 | 2019 | 494 | 0.130 |
Why?
|
Pedigree | 3 | 2019 | 4539 | 0.130 |
Why?
|
Receptor, EphA2 | 1 | 2016 | 41 | 0.130 |
Why?
|
Cohort Studies | 6 | 2020 | 41718 | 0.120 |
Why?
|
Algorithms | 4 | 2023 | 14098 | 0.120 |
Why?
|
Sports | 1 | 2021 | 704 | 0.120 |
Why?
|
Endodermal Sinus Tumor | 1 | 2015 | 53 | 0.120 |
Why?
|
Sensitivity and Specificity | 5 | 2020 | 14672 | 0.120 |
Why?
|
Urination Disorders | 2 | 2009 | 236 | 0.120 |
Why?
|
Silicon Dioxide | 1 | 2016 | 217 | 0.120 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2003 | 5716 | 0.120 |
Why?
|
Metabolome | 1 | 2021 | 1008 | 0.110 |
Why?
|
Molecular Sequence Data | 5 | 2015 | 17608 | 0.110 |
Why?
|
Dogs | 6 | 2004 | 3834 | 0.110 |
Why?
|
Hematuria | 2 | 2007 | 232 | 0.110 |
Why?
|
Treatment Outcome | 13 | 2018 | 65295 | 0.110 |
Why?
|
Urinary Diversion | 2 | 2019 | 134 | 0.110 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2017 | 633 | 0.110 |
Why?
|
Renal Insufficiency | 1 | 2019 | 812 | 0.110 |
Why?
|
Spermatic Cord Torsion | 1 | 2013 | 71 | 0.110 |
Why?
|
Carbohydrate Conformation | 1 | 2013 | 206 | 0.100 |
Why?
|
T-Box Domain Proteins | 1 | 2015 | 471 | 0.100 |
Why?
|
Hospitals, Pediatric | 2 | 2021 | 1856 | 0.100 |
Why?
|
Ribonucleases | 1 | 2013 | 266 | 0.100 |
Why?
|
Genes, Dominant | 1 | 2015 | 855 | 0.100 |
Why?
|
Adult | 14 | 2022 | 223317 | 0.100 |
Why?
|
Animals | 19 | 2018 | 168965 | 0.100 |
Why?
|
Subcellular Fractions | 1 | 2013 | 526 | 0.100 |
Why?
|
Costs and Cost Analysis | 1 | 2018 | 1666 | 0.100 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2012 | 112 | 0.090 |
Why?
|
Muscle, Smooth | 1 | 2015 | 930 | 0.090 |
Why?
|
Athletic Injuries | 1 | 2021 | 1245 | 0.090 |
Why?
|
Graft vs Host Disease | 1 | 2003 | 3049 | 0.090 |
Why?
|
Quality of Life | 2 | 2023 | 13485 | 0.090 |
Why?
|
Immunosuppressive Agents | 1 | 2003 | 4210 | 0.090 |
Why?
|
Molecular Weight | 1 | 2013 | 2168 | 0.090 |
Why?
|
Transplantation Chimera | 2 | 2003 | 594 | 0.090 |
Why?
|
Catalysis | 1 | 2012 | 766 | 0.090 |
Why?
|
Young Adult | 8 | 2022 | 59980 | 0.090 |
Why?
|
Methods | 1 | 2010 | 1065 | 0.090 |
Why?
|
Syndrome | 3 | 2022 | 3271 | 0.090 |
Why?
|
Brain Concussion | 1 | 2021 | 1431 | 0.090 |
Why?
|
Disease Susceptibility | 1 | 2017 | 1791 | 0.090 |
Why?
|
Mass Screening | 2 | 2020 | 5456 | 0.090 |
Why?
|
Infant, Newborn | 7 | 2020 | 26396 | 0.080 |
Why?
|
Blotting, Western | 1 | 2017 | 5022 | 0.080 |
Why?
|
Length of Stay | 3 | 2008 | 6489 | 0.080 |
Why?
|
Aging | 1 | 2008 | 8729 | 0.080 |
Why?
|
Chemical Precipitation | 1 | 2008 | 174 | 0.080 |
Why?
|
Biofeedback, Psychology | 1 | 2009 | 117 | 0.080 |
Why?
|
Ultrafiltration | 1 | 2008 | 47 | 0.080 |
Why?
|
Postoperative Complications | 4 | 2018 | 15824 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 36582 | 0.080 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 283 | 0.080 |
Why?
|
Radiation Dosage | 3 | 2011 | 1965 | 0.080 |
Why?
|
Mutation | 3 | 2019 | 30211 | 0.080 |
Why?
|
Fluorocarbons | 1 | 2013 | 501 | 0.070 |
Why?
|
Prognosis | 5 | 2019 | 29963 | 0.070 |
Why?
|
Urolithiasis | 1 | 2009 | 123 | 0.070 |
Why?
|
Albumins | 1 | 2010 | 577 | 0.070 |
Why?
|
Up-Regulation | 1 | 2017 | 4143 | 0.070 |
Why?
|
Peptides | 1 | 2020 | 4348 | 0.070 |
Why?
|
Prospective Studies | 4 | 2022 | 54886 | 0.070 |
Why?
|
Freezing | 1 | 2008 | 310 | 0.070 |
Why?
|
Nomograms | 1 | 2009 | 236 | 0.070 |
Why?
|
Age Factors | 2 | 2018 | 18401 | 0.070 |
Why?
|
Urinalysis | 1 | 2009 | 369 | 0.070 |
Why?
|
Orchiectomy | 2 | 2021 | 466 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2018 | 3468 | 0.070 |
Why?
|
Pilot Projects | 1 | 2020 | 8732 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2017 | 3511 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2902 | 0.060 |
Why?
|
Suture Techniques | 2 | 2008 | 775 | 0.060 |
Why?
|
Infant, Newborn, Diseases | 1 | 2010 | 587 | 0.060 |
Why?
|
Urodynamics | 1 | 2006 | 349 | 0.060 |
Why?
|
Stents | 2 | 2007 | 3193 | 0.060 |
Why?
|
Boston | 1 | 2018 | 9360 | 0.060 |
Why?
|
Transplantation, Homologous | 5 | 2005 | 4838 | 0.060 |
Why?
|
Risk Assessment | 3 | 2018 | 24299 | 0.060 |
Why?
|
Case Management | 1 | 2006 | 277 | 0.060 |
Why?
|
Fibronectins | 1 | 2008 | 722 | 0.060 |
Why?
|
Muscular Dystrophy, Animal | 1 | 2004 | 89 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3610 | 0.060 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20169 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20741 | 0.060 |
Why?
|
Rats, Wistar | 1 | 2008 | 1885 | 0.060 |
Why?
|
Graft Survival | 3 | 2003 | 3896 | 0.060 |
Why?
|
Protein Binding | 1 | 2016 | 9327 | 0.050 |
Why?
|
Operating Rooms | 1 | 2010 | 790 | 0.050 |
Why?
|
Appendix | 1 | 2004 | 110 | 0.050 |
Why?
|
Dystrophin | 1 | 2004 | 283 | 0.050 |
Why?
|
Cadherins | 1 | 2008 | 903 | 0.050 |
Why?
|
Isoantigens | 1 | 2005 | 562 | 0.050 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2004 | 897 | 0.050 |
Why?
|
Orchiopexy | 1 | 2021 | 21 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39317 | 0.050 |
Why?
|
Sphingosine | 1 | 2003 | 306 | 0.050 |
Why?
|
Congenital Abnormalities | 1 | 2006 | 703 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2003 | 793 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2011 | 5537 | 0.050 |
Why?
|
Decision Support Techniques | 1 | 2011 | 2006 | 0.050 |
Why?
|
Radiation Tolerance | 1 | 2003 | 476 | 0.050 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2005 | 1442 | 0.050 |
Why?
|
Graft Rejection | 2 | 2005 | 4498 | 0.050 |
Why?
|
Cyclosporine | 1 | 2003 | 778 | 0.040 |
Why?
|
Kidney Function Tests | 1 | 2003 | 683 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2013 | 5141 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4052 | 0.040 |
Why?
|
Genomic Imprinting | 1 | 2002 | 326 | 0.040 |
Why?
|
Reoperation | 2 | 2007 | 4325 | 0.040 |
Why?
|
MicroRNAs | 1 | 2016 | 3792 | 0.040 |
Why?
|
Mouth Mucosa | 1 | 2022 | 435 | 0.040 |
Why?
|
Middle Aged | 4 | 2020 | 223233 | 0.040 |
Why?
|
Computer Simulation | 1 | 2013 | 6260 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2006 | 2201 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2013 | 18330 | 0.040 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 17097 | 0.040 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2022 | 287 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2002 | 11097 | 0.040 |
Why?
|
Short Bowel Syndrome | 1 | 2002 | 352 | 0.040 |
Why?
|
Software | 1 | 2013 | 4472 | 0.040 |
Why?
|
Urinary Catheterization | 1 | 2019 | 195 | 0.040 |
Why?
|
Quality Improvement | 1 | 2014 | 3854 | 0.040 |
Why?
|
Transplantation Tolerance | 1 | 2003 | 639 | 0.040 |
Why?
|
Infant Care | 1 | 2019 | 182 | 0.040 |
Why?
|
Genes | 1 | 2002 | 1824 | 0.040 |
Why?
|
Ultrasonography, Prenatal | 1 | 2006 | 1772 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2006 | 22254 | 0.040 |
Why?
|
CpG Islands | 1 | 2002 | 1206 | 0.040 |
Why?
|
Mice, Inbred C57BL | 1 | 2016 | 22361 | 0.040 |
Why?
|
Pseudarthrosis | 1 | 1997 | 54 | 0.030 |
Why?
|
Rats | 2 | 2016 | 23713 | 0.030 |
Why?
|
Motion | 1 | 2020 | 784 | 0.030 |
Why?
|
Tissue Donors | 2 | 2005 | 2387 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 18063 | 0.030 |
Why?
|
Acute Disease | 2 | 2005 | 7236 | 0.030 |
Why?
|
Intestine, Small | 1 | 2002 | 1217 | 0.030 |
Why?
|
Vagina | 1 | 2022 | 849 | 0.030 |
Why?
|
Sirolimus | 1 | 2003 | 1539 | 0.030 |
Why?
|
Lung Transplantation | 1 | 2005 | 1310 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2022 | 1271 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2003 | 2710 | 0.030 |
Why?
|
Physician's Role | 1 | 2002 | 923 | 0.030 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2015 | 294 | 0.030 |
Why?
|
Time Factors | 4 | 2018 | 40154 | 0.030 |
Why?
|
Brachytherapy | 1 | 2002 | 1220 | 0.030 |
Why?
|
Risk | 1 | 2006 | 9606 | 0.030 |
Why?
|
Prostatectomy | 1 | 2002 | 1786 | 0.030 |
Why?
|
Athletes | 1 | 2021 | 1162 | 0.030 |
Why?
|
Bone Screws | 1 | 1997 | 533 | 0.030 |
Why?
|
Base Sequence | 3 | 2015 | 12414 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2276 | 0.030 |
Why?
|
Whole-Body Irradiation | 2 | 2004 | 435 | 0.030 |
Why?
|
Observer Variation | 1 | 2019 | 2616 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2015 | 874 | 0.030 |
Why?
|
Eating | 1 | 2019 | 1541 | 0.030 |
Why?
|
Swine, Miniature | 2 | 2005 | 972 | 0.020 |
Why?
|
Artifacts | 1 | 2020 | 1904 | 0.020 |
Why?
|
Sequence Analysis, Protein | 1 | 2013 | 261 | 0.020 |
Why?
|
Patient-Centered Care | 1 | 2002 | 1444 | 0.020 |
Why?
|
Swine | 3 | 2008 | 5987 | 0.020 |
Why?
|
Pediatrics | 1 | 2006 | 3621 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 935 | 0.020 |
Why?
|
Necrosis | 1 | 2015 | 1614 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 1997 | 978 | 0.020 |
Why?
|
Chronic Disease | 2 | 2021 | 9362 | 0.020 |
Why?
|
Survival Analysis | 1 | 2003 | 10092 | 0.020 |
Why?
|
Radioisotope Renography | 1 | 2010 | 61 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1788 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3804 | 0.020 |
Why?
|
Joint Instability | 1 | 1997 | 803 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2003 | 3305 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1903 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16718 | 0.020 |
Why?
|
Remission, Spontaneous | 1 | 2009 | 384 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2010 | 297 | 0.020 |
Why?
|
Survival Rate | 1 | 2003 | 12823 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 2628 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2726 | 0.020 |
Why?
|
DNA Methylation | 1 | 2002 | 4426 | 0.020 |
Why?
|
Spinal Fusion | 1 | 1997 | 1307 | 0.020 |
Why?
|
Rabbits | 1 | 2013 | 4751 | 0.020 |
Why?
|
Urinary Bladder Diseases | 1 | 2008 | 166 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3611 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2047 | 0.020 |
Why?
|
Markov Chains | 1 | 2010 | 976 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2495 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3552 | 0.020 |
Why?
|
United States | 3 | 2021 | 72971 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15424 | 0.020 |
Why?
|
Incidence | 2 | 2018 | 21526 | 0.020 |
Why?
|
Siblings | 1 | 2010 | 828 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2010 | 948 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4280 | 0.020 |
Why?
|
Electron Transport | 1 | 2006 | 211 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2006 | 355 | 0.020 |
Why?
|
Leukocytes | 2 | 2004 | 2034 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2003 | 15925 | 0.020 |
Why?
|
Chromatography, Affinity | 1 | 2006 | 524 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2010 | 1188 | 0.020 |
Why?
|
Ileum | 1 | 2008 | 558 | 0.020 |
Why?
|
Electrons | 1 | 2006 | 264 | 0.020 |
Why?
|
Acetylglucosamine | 1 | 2006 | 188 | 0.020 |
Why?
|
Aged | 1 | 2018 | 171319 | 0.020 |
Why?
|
Chromosome Mapping | 2 | 2004 | 4616 | 0.020 |
Why?
|
Mice | 4 | 2018 | 81912 | 0.010 |
Why?
|
Lectins | 1 | 2006 | 490 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4780 | 0.010 |
Why?
|
Hypersensitivity, Delayed | 1 | 2005 | 491 | 0.010 |
Why?
|
Biopsy | 1 | 2015 | 6777 | 0.010 |
Why?
|
Leukapheresis | 1 | 2003 | 150 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13646 | 0.010 |
Why?
|
Multifactorial Inheritance | 1 | 2010 | 1422 | 0.010 |
Why?
|
Histocompatibility Antigens | 1 | 2003 | 479 | 0.010 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2002 | 52 | 0.010 |
Why?
|
Liver Function Tests | 1 | 2003 | 526 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11063 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2004 | 13411 | 0.010 |
Why?
|
Chromosomes | 1 | 2004 | 578 | 0.010 |
Why?
|
Biomedical Research | 1 | 2017 | 3464 | 0.010 |
Why?
|
Isoantibodies | 1 | 2005 | 681 | 0.010 |
Why?
|
Open Reading Frames | 1 | 2004 | 818 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6210 | 0.010 |
Why?
|
Immunization | 1 | 2005 | 1218 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2002 | 1057 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2013 | 3370 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 30238 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11217 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14476 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2004 | 2745 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 12986 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2004 | 4167 | 0.010 |
Why?
|
Conserved Sequence | 1 | 2002 | 1160 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2005 | 1362 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 74886 | 0.010 |
Why?
|
Species Specificity | 1 | 2002 | 2412 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4572 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12069 | 0.010 |
Why?
|
Ilium | 1 | 1997 | 155 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2004 | 1596 | 0.010 |
Why?
|
Kinetics | 1 | 2003 | 6287 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3530 | 0.010 |
Why?
|
Databases, Factual | 1 | 2010 | 8068 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2002 | 2056 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2003 | 6310 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1997 | 2118 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7469 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10748 | 0.010 |
Why?
|
Heart | 1 | 2003 | 4429 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2005 | 10455 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2004 | 4968 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2010 | 26325 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2005 | 10254 | 0.000 |
Why?
|
Lung | 1 | 2005 | 10076 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2004 | 11923 | 0.000 |
Why?
|
Transcription Factors | 1 | 2002 | 12158 | 0.000 |
Why?
|